Smithfield Trust’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.47M | Buy |
7,039
+3,657
| +108% | +$1.3M | 0.11% | 100 |
|
|
2025
Q4 | $1.1M | Hold |
3,382
| – | – | 0.05% | 152 |
|
|
2025
Q3 | $942K | Sell |
3,382
-222
| -6% | -$64.4K | 0.04% | 160 |
|
|
2025
Q2 | $995K | Sell |
3,604
-36
| -1% | -$10.2K | 0.05% | 155 |
|
|
2025
Q1 | $1.12M | Sell |
3,640
-148
| -4% | -$43.7K | 0.06% | 142 |
|
|
2024
Q4 | $977K | Buy |
3,788
+120
| +3% | +$35.6K | 0.05% | 157 |
|
|
2024
Q3 | $1.18M | Buy |
3,668
+230
| +7% | +$75.2K | 0.06% | 141 |
|
|
2024
Q2 | $1.07M | Hold |
3,438
| – | – | 0.06% | 139 |
|
|
2024
Q1 | $974K | Hold |
3,438
| – | – | 0.05% | 150 |
|
|
2023
Q4 | $983K | Sell |
3,438
-44
| -1% | -$12K | 0.06% | 143 |
|
|
2023
Q3 | $930K | Hold |
3,482
| – | – | 0.06% | 138 |
|
|
2023
Q2 | $771K | Sell |
3,482
-93
| -3% | -$21.6K | 0.05% | 156 |
|
|
2023
Q1 | $860K | Buy |
3,575
+114
| +3% | +$28K | 0.06% | 141 |
|
|
2022
Q4 | $908K | Sell |
3,461
-50
| -1% | -$13.4K | 0.06% | 130 |
|
|
2022
Q3 | $790K | Buy |
3,511
+38
| +1% | +$9.21K | 0.06% | 133 |
|
|
2022
Q2 | $844K | Sell |
3,473
-150
| -4% | -$36.8K | 0.06% | 133 |
|
|
2022
Q1 | $875K | Hold |
3,623
| – | – | 0.06% | 140 |
|
|
2021
Q4 | $812K | Sell |
3,623
-82
| -2% | -$17.3K | 0.05% | 155 |
|
|
2021
Q3 | $789K | Buy |
3,705
+100
| +3% | +$23K | 0.05% | 152 |
|
|
2021
Q2 | $879K | Hold |
3,605
| – | – | 0.06% | 140 |
|
|
2021
Q1 | $897K | Sell |
3,605
-545
| -13% | -$130K | 0.06% | 136 |
|
|
2020
Q4 | $954K | Buy |
4,150
+117
| +3% | +$27K | 0.07% | 128 |
|
|
2020
Q3 | $1.02M | Buy |
4,033
+44
| +1% | +$10.9K | 0.08% | 118 |
|
|
2020
Q2 | $941K | Buy |
3,989
+478
| +14% | +$109K | 0.08% | 116 |
|
|
2020
Q1 | $712K | Sell |
3,511
-122
| -3% | -$26.6K | 0.07% | 123 |
|
|
2019
Q4 | $876K | Sell |
3,633
-9
| -0.2% | -$1.98K | 0.08% | 122 |
|
|
2019
Q3 | $705K | Buy |
3,642
+100
| +3% | +$19.2K | 0.07% | 132 |
|
|
2019
Q2 | $653K | Buy |
3,542
+101
| +3% | +$18.1K | 0.07% | 133 |
|
|
2019
Q1 | $654K | Sell |
3,441
-399
| -10% | -$76.2K | 0.07% | 135 |
|
|
2018
Q4 | $748K | Buy |
3,840
+382
| +11% | +$74.5K | 0.09% | 111 |
|
|
2018
Q3 | $717K | Buy |
3,458
+63
| +2% | +$12.4K | 0.08% | 132 |
|
|
2018
Q2 | $627K | Sell |
3,395
-210
| -6% | -$37.1K | 0.07% | 132 |
|
|
2018
Q1 | $614K | Sell |
3,605
-290
| -7% | -$53.2K | 0.07% | 136 |
|
|
2017
Q4 | $678K | Sell |
3,895
-43
| -1% | -$7.61K | 0.08% | 134 |
|
|
2017
Q3 | $734K | Sell |
3,938
-48
| -1% | -$8.51K | 0.1% | 120 |
|
|
2017
Q2 | $687K | Sell |
3,986
-90
| -2% | -$14.6K | 0.1% | 125 |
|
|
2017
Q1 | $669K | Sell |
4,076
-255
| -6% | -$42.4K | 0.1% | 124 |
|
|
2016
Q4 | $633K | Sell |
4,331
-158
| -4% | -$23.8K | 0.11% | 130 |
|
|
2016
Q3 | $749K | Buy |
4,489
+1,321
| +42% | +$223K | 0.13% | 99 |
|
|
2016
Q2 | $482K | Buy |
3,168
+159
| +5% | +$24.7K | 0.09% | 138 |
|
|
2016
Q1 | $451K | Buy |
3,009
+33
| +1% | +$4.9K | 0.09% | 150 |
|
|
2015
Q4 | $483K | Buy |
2,976
+113
| +4% | +$17.8K | 0.1% | 136 |
|
|
2015
Q3 | $396K | Buy |
2,863
+91
| +3% | +$14.3K | 0.08% | 158 |
|
|
2015
Q2 | $425K | Buy |
2,772
+60
| +2% | +$9.61K | 0.08% | 163 |
|
|
2015
Q1 | $434K | Sell |
2,712
-385
| -12% | -$60.6K | 0.09% | 174 |
|
|
2014
Q4 | $493K | Buy |
3,097
+42
| +1% | +$6.54K | 0.1% | 148 |
|
|
2014
Q3 | $429K | Sell |
3,055
-722
| -19% | -$94.3K | 0.09% | 180 |
|
|
2014
Q2 | $447K | Sell |
3,777
-821
| -18% | -$95K | 0.09% | 184 |
|
|
2014
Q1 | $567K | Buy |
4,598
+56
| +1% | +$6.79K | 0.11% | 147 |
|
|
2013
Q4 | $518K | Sell |
4,542
-38
| -0.8% | -$4.32K | 0.11% | 159 |
|
|
2013
Q3 | $513K | Sell |
4,580
-658
| -13% | -$71.3K | 0.12% | 139 |
|
|
2013
Q2 | $517K | Buy |
+5,238
| New | +$544K | 0.12% | 135 |
|
Other funds holding AMGN
VCM
VPM
Smithfield Trust's AMGN Position: Q1 2026 in Review
Smithfield Trust increased its Amgen (AMGN) stake by 108% in Q1 2026, buying an estimated $1.3M and bringing the position to 7,039 shares worth $2.47M. The position accounts for 0.11% of the portfolio, ranked #100.
Smithfield Trust first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Smithfield Trust held 7,039 shares of Amgen worth $2.47M as of Q1 2026.
- Smithfield Trust bought 3,657 Amgen shares in Q1 2026, an estimated $1.3M.
- Amgen made up 0.11% of Smithfield Trust's portfolio in Q1 2026, its #100 holding.
- Smithfield Trust first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
- 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.